267 related articles for article (PubMed ID: 11437233)
1. Emerging connections between DNA methylation and histone acetylation.
Dobosy JR; Selker EU
Cell Mol Life Sci; 2001 May; 58(5-6):721-7. PubMed ID: 11437233
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing. Methylation meets acetylation.
Bestor TH
Nature; 1998 May; 393(6683):311-2. PubMed ID: 9620794
[No Abstract] [Full Text] [Related]
3. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
4. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
[TBL] [Abstract][Full Text] [Related]
5. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
Sharma D; Blum J; Yang X; Beaulieu N; Macleod AR; Davidson NE
Mol Endocrinol; 2005 Jul; 19(7):1740-51. PubMed ID: 15746193
[TBL] [Abstract][Full Text] [Related]
6. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.
Jones PL; Veenstra GJ; Wade PA; Vermaak D; Kass SU; Landsberger N; Strouboulis J; Wolffe AP
Nat Genet; 1998 Jun; 19(2):187-91. PubMed ID: 9620779
[TBL] [Abstract][Full Text] [Related]
7. Chromatin remodeling, histone modifications, and DNA methylation-how does it all fit together?
Geiman TM; Robertson KD
J Cell Biochem; 2002; 87(2):117-25. PubMed ID: 12244565
[TBL] [Abstract][Full Text] [Related]
8. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
Fuks F; Hurd PJ; Wolf D; Nan X; Bird AP; Kouzarides T
J Biol Chem; 2003 Feb; 278(6):4035-40. PubMed ID: 12427740
[TBL] [Abstract][Full Text] [Related]
9. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
10. Global effects of histone modifications.
He H; Lehming N
Brief Funct Genomic Proteomic; 2003 Oct; 2(3):234-43. PubMed ID: 15239926
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
Nan X; Ng HH; Johnson CA; Laherty CD; Turner BM; Eisenman RN; Bird A
Nature; 1998 May; 393(6683):386-9. PubMed ID: 9620804
[TBL] [Abstract][Full Text] [Related]
12. Co-repressor complexes and remodelling chromatin for repression.
Wolffe AP; Urnov FD; Guschin D
Biochem Soc Trans; 2000; 28(4):379-86. PubMed ID: 10961924
[TBL] [Abstract][Full Text] [Related]
13. Evidence that Set1, a factor required for methylation of histone H3, regulates rDNA silencing in S. cerevisiae by a Sir2-independent mechanism.
Bryk M; Briggs SD; Strahl BD; Curcio MJ; Allis CD; Winston F
Curr Biol; 2002 Jan; 12(2):165-70. PubMed ID: 11818070
[TBL] [Abstract][Full Text] [Related]
14. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
Lorincz MC; Schübeler D; Groudine M
Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase: a regulator of transcription.
Wolffe AP
Science; 1996 Apr; 272(5260):371-2. PubMed ID: 8602525
[No Abstract] [Full Text] [Related]
16. Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain.
Grandjean V; O'Neill L; Sado T; Turner B; Ferguson-Smith A
FEBS Lett; 2001 Jan; 488(3):165-9. PubMed ID: 11163765
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and chromatin - unraveling the tangled web.
Robertson KD
Oncogene; 2002 Aug; 21(35):5361-79. PubMed ID: 12154399
[TBL] [Abstract][Full Text] [Related]
19. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
20. 5-Aza-2'-deoxycytidine induces histone hyperacetylation of mouse centromeric heterochromatin by a mechanism independent of DNA demethylation.
Takebayashi S; Nakao M; Fujita N; Sado T; Tanaka M; Taguchi H; Okumura K
Biochem Biophys Res Commun; 2001 Nov; 288(4):921-6. PubMed ID: 11688997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
